Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Liberty Media Series A
FWONA
$22.9B
| $38.2M | 0.02% |
658,690
+260,236
| +65% | +$15.1M |
|
427
Ashland
ASH
$2.44B
| $38.2M | 0.02% |
452,819
+429,332
| +1,828% | +$36.2M |
|
428
Metallus
MTUS
$683M
| $37.7M | 0.02% |
1,609,420
-32
| -0% | -$750 |
|
429
The Bancorp
TBBK
$3.47B
| $37.5M | 0.02% |
973,134
+6,531
| +0.7% | +$252K |
|
430
Janus International
JBI
$1.39B
| $37.4M | 0.02% |
2,867,146
+35,284
| +1% | +$460K |
|
431
Bath & Body Works
BBWI
$5.82B
| $37.3M | 0.02% |
865,002
-96,112
| -10% | -$4.15M |
|
432
Meritage Homes
MTH
$5.63B
| $37.1M | 0.02% |
425,568
-3,580
| -0.8% | -$312K |
|
433
Labcorp
LH
$23.1B
| $36.9M | 0.02% |
162,220
-68,779
| -30% | -$15.6M |
|
434
Waste Connections
WCN
$45.7B
| $36.8M | 0.02% |
246,239
-61,005
| -20% | -$9.11M |
|
435
Criteo
CRTO
$1.21B
| $36.1M | 0.02% |
1,426,424
+75,180
| +6% | +$1.9M |
|
|
VRNA
436
Verona Pharma
VRNA
$9.19B
| $35.8M | 0.02% |
1,803,361
+166,539
| +10% | +$3.31M |
|
437
Ball Corp
BALL
$13.7B
| $35.7M | 0.02% |
621,016
+403,597
| +186% | +$23.2M |
|
438
TC Energy
TRP
$53.9B
| $35.7M | 0.02% |
909,564
-77,350
| -8% | -$3.04M |
|
439
BWX Technologies
BWXT
$14.8B
| $35.7M | 0.02% |
464,768
-90,905
| -16% | -$6.98M |
|
440
Cable One
CABO
$913M
| $35.4M | 0.02% |
63,587
-14
| -0% | -$7.79K |
|
441
The Beauty Health Co
SKIN
$309M
| $35.1M | 0.02% |
11,299,927
-267,266
| -2% | -$831K |
|
|
AMED
442
DELISTED
Amedisys
AMED
| $35.1M | 0.02% |
369,753
-103,750
| -22% | -$9.86M |
|
|
CLVT.PRA
443
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $35.1M | 0.02% |
955,143
| – | – |
|
|
ITCI
444
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $35M | 0.02% |
489,137
+8,864
| +2% | +$635K |
|
445
Ultra Clean Holdings
UCTT
$1.11B
| $34.8M | 0.02% |
1,019,030
+98,538
| +11% | +$3.36M |
|
446
Azenta
AZTA
$1.35B
| $34.5M | 0.02% |
529,170
-4,676
| -0.9% | -$305K |
|
447
Atlas Energy Solutions
AESI
$1.3B
| $34.4M | 0.02% |
1,999,288
+16,569
| +0.8% | +$285K |
|
448
Etsy
ETSY
$5.55B
| $34.4M | 0.02% |
424,521
-1,578
| -0.4% | -$128K |
|
449
Canadian Pacific Kansas City
CP
$68.6B
| $33.9M | 0.02% |
428,597
-543
| -0.1% | -$43K |
|
450
Nomad Foods
NOMD
$2.13B
| $33.9M | 0.02% |
1,999,835
+163,028
| +9% | +$2.76M |
|